Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.
Slapped with Rs 242-crore fine by US authorities for rule violations at Toansa unit, say sources; 2nd such hefty rap in the recent past from US regulators for bending rules.
At $37 per dose, the Pfizer vaccine is much more expensive compared to $3 per dose for the Covishield.
Analysts are eyeing bigger launches that will positively impact company's fortunes.
The BSE Midcap also cut all its intraday gains to shed 0.3% at close
A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations.
OBC leader Dharam Singh Saini on Thursday became the third minister to resign from the Uttar Pradesh cabinet this week, giving yet another jolt to the ruling Bharatiya Janata Party in the run-up to the assembly polls.
The vaccine arrives at a critical moment for the US. Hospitalisations due to COVID-19 hit record highs for the seventh day in a row on Saturday.
Many countries found Maggi noodles to be safe for consumption.
Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India, has quit and so have a few other key officials at the American drug regulator's India office.
Trump also raised the possibility of using light to combat the deadly viral infection.
These vaccines have not yet been approved by the World Health Organization
The US Food and Drug Administration said on Sunday that over 70,000 patients in the country had been treated with convalescent plasma, which is made using the blood of people who have recovered from coronavirus infections.
The names of two Indian-Americans -- Seema Verma and Bobby Jindal -- have emerged as possible candidates.
"Due to scheduling reasons, it is inconvenient for China to attend the meeting," Chinese Foreign Ministry spokesman Wang Wenbin told mediapersons.
Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.
The news that exports to the US will not restart before next year as well as the September quarter performance are sentiment dampeners.
Low growth visibility and trouble with regulators have resulted in lack of interest from investors
.jpg)
To focus on molecules at advanced stage of development; move to impact 200 scientists.
The company has received a communication from the Medicines and Healthcare Products Regulatory Agency, United Kingdom, whereby the agency has decided to withdraw the previously issued GMP Certificate to the company's manufacturing facility situated at Kadaiya, Nani Daman, Wockhardt said in a filing to the Bombay Stock Exchange.
Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.
The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
This is not just a Ranbaxy or Wockhardt problem, says K Satish Reddy
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
Test reports from UP food regulator started the controversy.
The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.
The under-one-minute films are titled 'Menu Cards, Mom and Neighbours'.
Gujarat has around 3,000 licensees for allopathic drug manufacturing, apart from around seven homeopathic licensees, 500 ayuvedic and 600-700 cosmetics licensees
Of the 30-share Sensex pack, 22 ended with losses while NTPC ended flat at Rs 127.30.
Roadshows will be held in Singapore, Hong Kong, London, New York and Boston, NTPC gained close to 1%.
The global heath body had earlier suspended the hydroxychloroquine arm of the clinical trials of experimental COVID-19 drugs over safety concerns.
Inspections only in domestic authorities' presence, visiting US drug regulator told
The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region.
Elizabeth Holmes founded Theranos in 2003 and it promised ground-breaking methods that would allow quick results for a wide range of tests with just one drop of blood.
Pharma was the top losing index amid worries about their earnings outlook with Lupin down over 4%
4 Ranbaxy facilities in India have been barred from exporting to US.
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.
Its Waluj manufacturing facility in Maharashtra failed to meet the good manufacturing norms prescribed by the UK drug regulator.
South-east Asian countries are emerging as preferable destination for India's pharma companies to expand their business as they share similar patient population and disease profile and moreover, have a conducive environment for their operations like easy market approach without any regulatory uncertainty, the survey of Indian pharma firms highlighted.
'The Centre and state need to take a unified approach and take concerted action before this matter assumes menacing proportions because unemployment, the drug trade and the levels of frustration among the youth make them vulnerable to any maverick who promises something better.'
